190 related articles for article (PubMed ID: 222798)
21. A re-evaluation of the skin test of herpes simplex virus.
Yamamoto Y
Jpn J Microbiol; 1966 Apr; 10(1):67-77. PubMed ID: 4289633
[No Abstract] [Full Text] [Related]
22. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
23. [A simple and rapid method of determining the titer of herpes simplex virus antibodies in a study by immunoenzyme analysis of a single serum dilution].
Kibardin VM; Ebralidze LK; Zvonarev AIu
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):61-3. PubMed ID: 2540601
[TBL] [Abstract][Full Text] [Related]
24. Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection.
Sherlock CH; Ashley RL; Shurtleff ML; Mack KD; Corey L
J Clin Microbiol; 1986 Dec; 24(6):1093-7. PubMed ID: 3023439
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a new latex agglutination method for detection of antibody to herpes simplex virus.
DeGirolami PC; Dakos J; Eichelberger K; Biano S
J Clin Microbiol; 1988 May; 26(5):1024-5. PubMed ID: 2838501
[TBL] [Abstract][Full Text] [Related]
26. Antigens of herpes simplex virus of oral and genital origin.
Wildy P
Cancer Res; 1973 Jun; 33(6):1465-8. PubMed ID: 4124113
[No Abstract] [Full Text] [Related]
27. Detection of herpesvirus type-specific antibody by a micro solid phase radioimmunometric assay.
Dreesman GR; Matson DO; Courtney RJ; Adam E; Melnick JL
Intervirology; 1979; 12(2):115-9. PubMed ID: 94044
[TBL] [Abstract][Full Text] [Related]
28. Immune adherence hemagglutination test applied to the study of herpes simplex and varicella-zoster virus infections.
Gillani A; Spence L
J Clin Microbiol; 1978 Feb; 7(2):114-7. PubMed ID: 204662
[TBL] [Abstract][Full Text] [Related]
29. Neutralization antibody to herpes simplex virus type 1 in Bell's palsy.
Nakamura K; Yanagihara N
Ann Otol Rhinol Laryngol Suppl; 1988; 137():18-21. PubMed ID: 2849360
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases.
Leventon-Kriss S; Rannon L; Joffe R
Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656
[TBL] [Abstract][Full Text] [Related]
31. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
Jankowski MA; Petersen EE; Böcker JF
Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of solid-phase immunofluorescence for quantitation of antibodies to herpes simplex virus and cytomegalovirus.
Benjamin WR; Specter SC; Klein TW; Hitchings M; Friedman H
J Clin Microbiol; 1980 Oct; 12(4):558-61. PubMed ID: 6252245
[TBL] [Abstract][Full Text] [Related]
33. Comparison of indirect hemagglutination and 51chromium release tests for detection of Herpes Simplex Virus type 1 and 2 antibodies in patients with recurrent Herpes infections.
Kesavalu L; Seth P
Arch Virol; 1980; 66(2):77-88. PubMed ID: 6254476
[TBL] [Abstract][Full Text] [Related]
34. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.
Arsenakis M; May JT
Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunoassay for the detection of IgG antibodies to herpes simplex virus and its use as a prognostic indicator of HSV excretion in transplant recipients.
Berry NJ; Grundy JE; Griffiths PD
J Med Virol; 1987 Feb; 21(2):147-54. PubMed ID: 3029319
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous dissemination of herpes simplex virus in individuals fifteen years of age and older.
Cesario T; Fife LT; Rayhan S; Emmons R
Am J Med Sci; 1977; 273(3):345-53. PubMed ID: 194479
[TBL] [Abstract][Full Text] [Related]
37. Indirect hemagglutinating antibody response to Herpesvirus hominis types 1 and 2 in immunized laboratory animals and in natural infections of man.
Back AF; Schmidt NJ
Appl Microbiol; 1974 Sep; 28(3):392-9. PubMed ID: 4371513
[TBL] [Abstract][Full Text] [Related]
38. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
[No Abstract] [Full Text] [Related]
39. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test.
Arsenakis M; May JT
Br J Vener Dis; 1982 Feb; 58(1):48-51. PubMed ID: 6275941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
